Characterizing Carbapenemase Gene Transmission in CREC: Insights from a Guangdong Multi-Hospital Study

Study Background and Research Question

The global escalation of antimicrobial resistance among Gram-negative pathogens has placed carbapenem-resistant Enterobacter cloacae (CREC) in the spotlight, particularly as a leading cause of healthcare-associated infections. The COVID-19 pandemic has further complicated the resistance landscape, with increased antibiotic usage and disruptions in standard infection control potentially accelerating the emergence and spread of multidrug-resistant organisms. Despite this, detailed molecular epidemiology of carbapenemase-encoding genes (CEGs) in CREC, especially regarding their transmission dynamics during the pandemic, remains limited. The referenced study by Chen et al. (2025) addresses this gap by comprehensively analyzing CREC isolates from eight teaching hospitals in Guangdong Province, China, collected between December 2022 and June 2024.

Key Innovation from the Reference Study

The primary innovation of Chen et al.'s work lies in its dual focus: high-resolution detection of CEGs (notably blaNDM−1, blaIMP, and blaKPC−2) and systematic mapping of their transmission via both plasmids and chromosomes. By coupling plasmid elimination techniques with robust genotyping and conjugation assays, the study uncovers not only the prevalence of CEGs in clinical CREC but also their remarkable capacity for horizontal gene transfer. This dual-layered approach provides new quantitative insights into how resistance determinants propagate within and between hospital environments during a period of heightened clinical stress.

Methods and Experimental Design Insights

The investigators utilized a suite of molecular and microbiological tools to dissect the genetic basis and mobility of carbapenem resistance. Key elements of the workflow included:

• Isolate Collection: Fifty-four non-duplicate CREC isolates were obtained from eight geographically diverse teaching hospitals over an 18-month period, ensuring representative sampling across departments and patient demographics.
• Plasmid Curing and Gene Localization: Variable temperature SDS-based plasmid elimination was used to distinguish plasmid-borne from chromosomal CEGs, complemented by targeted PCR assays to confirm gene presence and localization.
• Antimicrobial Susceptibility Testing: The broth microdilution method quantified resistance profiles to a panel of clinically relevant antibiotics, enabling correlation of CEG status with phenotypic multidrug resistance.
• Conjugation Experiments: Mating assays probed the efficiency of horizontal gene transfer, with PCR confirmation of CEGs in transconjugants.
• Mobile Genetic Element Analysis: Six classes of insertion sequences and transposons were mapped to contextualize gene mobility, with ISEcp1 emerging as the most prevalent element.
• Genotyping: ERIC-PCR coupled with NTSYS cluster analysis delineated 17 genotypes among the isolates, revealing clonal dissemination patterns across hospitals.

Protocol Parameters

• Variable temperature SDS plasmid curing: Conducted per isolate, typically at elevated temperatures to destabilize plasmid maintenance.
• Broth microdilution for susceptibility: Applied according to CLSI guidelines, with endpoints defined by visible growth inhibition.
• Conjugation assays: Recipient strains exposed to donor CREC isolates; transconjugants selected on antibiotic-containing media for CEG detection.
• PCR primer specificity: Targeted for blaNDM−1, blaKPC−2, blaIMP, and associated mobile elements, following established molecular protocols.

Core Findings and Why They Matter

The study reveals a high burden of CEGs among CREC isolates: 85.2% (46/54) carried at least one carbapenemase gene, with blaNDM−1 being the most prevalent. Notably, 33.3% of isolates harbored blaNDM−1 on both chromosomes and plasmids, while 46.3% carried it exclusively on plasmids. This underscores the central role of plasmid-mediated dissemination in the regional spread of carbapenem resistance. The plasmid conjugation success rate was strikingly high at 95.7% among CEG-positive isolates, and nearly all blaNDM−1 and blaIMP genes were transferable—highlighting the efficiency of horizontal gene transfer in clinical settings.

Phenotypically, CEG-positive strains exhibited significantly greater resistance to multiple antibiotics, including imipenem, cefepime, gentamicin, ceftazidime/avibactam, ciprofloxacin, and levofloxacin, compared to CEG-negative counterparts (see study data). The prevalence of the ISEcp1 insertion sequence in 87% of isolates further emphasizes the facilitative role of mobile genetic elements in propagating resistance determinants. Genotyping revealed that the most common CREC clones were distributed across different hospitals and departments, indicating inter-facility transmission routes.

Demographic analysis showed higher detection rates of CEG-positive CREC in men, elderly patients, respiratory medicine wards, and sputum samples. This epidemiological pattern aligns with broader trends in hospital-acquired infections and informs targeted surveillance strategies.

Comparison with Existing Internal Articles

Several internal resources, such as "Chloramphenicol in Plasmid Selection: Protocols & Resistance Insights" and "Chloramphenicol in Plasmid Selection: Protocols & Advanced Uses", provide practical laboratory perspectives on tracking resistance gene transmission using plasmid selection assays. These resources underscore the importance of robust selection agents—such as Chloramphenicol (2,2-dichloro-N-[(1R,2R)-1,3-dihydroxy-1-(4-nitrophenyl)propan-2-yl]acetamide)—in mapping resistance gene mobility and maintaining reproducibility in molecular workflows. The current study's focus on plasmid-borne CEGs and conjugation efficiency directly parallels the methodological frameworks detailed in these internal guides, bridging clinical surveillance with laboratory assay optimization.

Limitations and Transferability

While Chen et al.'s findings provide a robust snapshot of CEG dynamics in Guangdong hospitals, several limitations exist. First, the study's regional focus may limit generalizability to other geographic or healthcare contexts. Second, the sampling window, though spanning 18 months, coincided with pandemic-related disruptions, which may have influenced resistance patterns. Additionally, the study concentrated on major CEGs but did not exhaustively survey all potential resistance determinants. Nevertheless, the molecular workflows—including plasmid curing, conjugation, and genotyping—are broadly transferable to other Enterobacteriaceae and hospital surveillance settings.

Research Support Resources

For researchers seeking to replicate or extend these findings in laboratory settings, validated reagents and protocols are essential. Chloramphenicol, a well-characterized bacterial protein synthesis inhibitor and antimicrobial agent, remains a cornerstone for plasmid selection assay workflows. Its mechanism—specific binding to the bacterial 50S ribosomal subunit and inhibition of peptidyl transferase activity—facilitates stringent selection and resistance gene tracking in molecular biology research. For high-purity, workflow-ready applications, Chloramphenicol (SKU A2512) from APExBIO can be used to maintain selection pressure in Enterobacteriaceae-based assays, as described in related internal articles. Researchers are advised to follow established storage and handling recommendations to ensure reproducibility and experimental integrity.